The initial product to be jointly promoted in the US is Teva?s ProAir ® HFA (albuterol sulfate) Inhalation Aerosol. ProAir ® HFA is the number-one branded ...
The initial product to be jointly promoted in the US is Teva's ProAir HFA (albuterol sulfate) Inhalation Aerosol. Additionally, the agreement will provide ...
... and its claim against Dey involved a number of drugs prescribed primarily for pulmonary diseases and asthma, such as albuterol sulfate and ipratropium ...
... claim against Dey involved a number of drugs prescribed primarily for pulmonary diseases and asthma, such as Albuterol Sulfate and Ipratropium Bromide. ...
Watson Pharmaceuticals (WPI) gets final approval from FDA on its Abbreviated New Drug Application for Ipratropium Bromide and Albuterol Sulfate Inhalation ...
... its generic version of Dey's bronchodilator, DuoNeb (Albuterol Sulfate and Ipratropium Bromide) Inhalation Solution, 3 mg (0.083%) and 0.5 mg (0.017%). ...
... its generic version of Dey's bronchodilator, DuoNeb (Albuterol Sulfate and Ipratropium Bromide) Inhalation Solution, 3 mg (0.083%) and 0.5 mg (0.017%). ...
Watson's Ipratropium Bromide and Albuterol Sulfate product is the generic version of Dey, LP's DuoNeb. The drug is indicated for the treatment of ...
... its generic version of Dey’s bronchodilator, DuoNeb® (Albuterol Sulfate and Ipratropium Bromide) Inhalation Solution, 3 mg (0.083%) and 0.5 mg (0.017%). ...
The Food and Drug Administration approved Israel-based Teva's abbreviated new drug application for the albuterol sulfate and ipratropium bromide inhalation ...